Matches in Nanopublications for { ?s ?p "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- NP284930.RAdjs9F7euTBnnTQoxIWIPCJ70IM5RkZY8-DbgdwAQ7HE130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284930.RAdjs9F7euTBnnTQoxIWIPCJ70IM5RkZY8-DbgdwAQ7HE130_provenance.
- NP404840.RAZsXseFL6JOcTqdhqeKb_59yedpxkiU6dXrnZdI40vFo130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP404840.RAZsXseFL6JOcTqdhqeKb_59yedpxkiU6dXrnZdI40vFo130_provenance.
- NP870882.RAgrFU8VT1ndFKZvcy7M8ytSU9IDYbL43LpgX-2jthi3g130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870882.RAgrFU8VT1ndFKZvcy7M8ytSU9IDYbL43LpgX-2jthi3g130_provenance.
- NP524047.RA3ryCrk1XhvrZBo0d9Y1K44D6yEblmr0aF6i4rZvZoMs130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524047.RA3ryCrk1XhvrZBo0d9Y1K44D6yEblmr0aF6i4rZvZoMs130_provenance.
- NP710505.RAWK6ZFBoHVet37p_Ab7DlQHZHZCaj2dmZHgNeiHi1f0k130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710505.RAWK6ZFBoHVet37p_Ab7DlQHZHZCaj2dmZHgNeiHi1f0k130_provenance.
- assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP852348.RAx5EqYRF5Q75Wlo8bf7xhy4tNIMToEZWw9WTbnxW__1I130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852348.RAx5EqYRF5Q75Wlo8bf7xhy4tNIMToEZWw9WTbnxW__1I130_provenance.
- NP451949.RAHQ2kS_-mA7Fe6YDmyi8pg_7b9jyROrs3ivSVq8O1uxo130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451949.RAHQ2kS_-mA7Fe6YDmyi8pg_7b9jyROrs3ivSVq8O1uxo130_provenance.
- assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP965692.RABoSG1l9Su5DLOHfMyRIFCkwJeh1sWlR2g7v3BC6nX5o130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965692.RABoSG1l9Su5DLOHfMyRIFCkwJeh1sWlR2g7v3BC6nX5o130_provenance.
- NP841545.RABgd-6B2aQA4-KbUKA7HuFGi5HDPaVmCVZsUfoUoSF_8130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841545.RABgd-6B2aQA4-KbUKA7HuFGi5HDPaVmCVZsUfoUoSF_8130_provenance.
- NP524316.RAj4T0p-gybUIyZYBt_euKwsiGa0phJOYJsWV13mBN2CY130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524316.RAj4T0p-gybUIyZYBt_euKwsiGa0phJOYJsWV13mBN2CY130_provenance.
- NP524369.RAhTbOXrb1A-XWMUbl5RTtgIanI8EeHL1CcTMvYuF7iz0130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524369.RAhTbOXrb1A-XWMUbl5RTtgIanI8EeHL1CcTMvYuF7iz0130_provenance.
- NP524571.RAs521JEuBM_3JYqHgTv57g-LZ9RlPve-xgwPFPCLhwLc130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524571.RAs521JEuBM_3JYqHgTv57g-LZ9RlPve-xgwPFPCLhwLc130_provenance.
- NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_provenance.
- NP524578.RAC8uUdK8fodSnT4vudaxGmKGZtbdLK6pvFX46VF9b1e0130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524578.RAC8uUdK8fodSnT4vudaxGmKGZtbdLK6pvFX46VF9b1e0130_provenance.
- NP452174.RAuSPs7fsUFD76PoptsPfUtZbPXTJIf-uEyEIQKAGw50g130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452174.RAuSPs7fsUFD76PoptsPfUtZbPXTJIf-uEyEIQKAGw50g130_provenance.
- NP452293.RAiFU3xUycYwujxvyXW7fuWIDaQO0tWAajRb5pJ0bVoTE130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452293.RAiFU3xUycYwujxvyXW7fuWIDaQO0tWAajRb5pJ0bVoTE130_provenance.
- NP965744.RAuWZuMakwWTULL-r1ZUT9btcXOY53IpnOZc4d7wObWwM130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965744.RAuWZuMakwWTULL-r1ZUT9btcXOY53IpnOZc4d7wObWwM130_provenance.
- NP895764.RAKMuayLk88e31dO9PBQ7RBeyJrLKBY2ae9ZdbjIqfjic130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895764.RAKMuayLk88e31dO9PBQ7RBeyJrLKBY2ae9ZdbjIqfjic130_provenance.
- NP841546.RAiHiEL5pOeK95QQVLP4Zcz9m98SgITklDMpNpfoTCc5w130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841546.RAiHiEL5pOeK95QQVLP4Zcz9m98SgITklDMpNpfoTCc5w130_provenance.
- NP841548.RAvrehMSUjk7Uw8CKNHNmim-uyb-ELqnw-YE89krvZ5as130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841548.RAvrehMSUjk7Uw8CKNHNmim-uyb-ELqnw-YE89krvZ5as130_provenance.
- NP841553.RAn58Hk8nj1-NdppzCxkVtvZgctS_Z42yqfrGQN4pizOY130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841553.RAn58Hk8nj1-NdppzCxkVtvZgctS_Z42yqfrGQN4pizOY130_provenance.
- NP841554.RAvjkvPh0tK40AGqC9EUkiLEmRQLBAOKg3FXNmSNsQbxY130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841554.RAvjkvPh0tK40AGqC9EUkiLEmRQLBAOKg3FXNmSNsQbxY130_provenance.
- NP1012611.RA_LEJGbwS4urQm5yU250PquzxtWSPMQ8zJbGqz6ayij0130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012611.RA_LEJGbwS4urQm5yU250PquzxtWSPMQ8zJbGqz6ayij0130_provenance.
- NP1012663.RA9KFH8w4PQQBhhAfmKf47sRy_xQkX7BvkBwUNmObr2UY130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012663.RA9KFH8w4PQQBhhAfmKf47sRy_xQkX7BvkBwUNmObr2UY130_provenance.
- NP841547.RAKVNeOO7RtEc3vkHSciRLdfTZpqHf7g9y3f0YMlBVLKI130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841547.RAKVNeOO7RtEc3vkHSciRLdfTZpqHf7g9y3f0YMlBVLKI130_provenance.
- NP841549.RAP1WQHu4rGlsSg5BYCe9fHWzQUzrDCYyOVJFCx6Q4cWw130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841549.RAP1WQHu4rGlsSg5BYCe9fHWzQUzrDCYyOVJFCx6Q4cWw130_provenance.
- NP841551.RAJCSG90ehv91VKTln05I2avei-eDAZeJapiqBE7Pkf78130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841551.RAJCSG90ehv91VKTln05I2avei-eDAZeJapiqBE7Pkf78130_provenance.
- NP841557.RAFSzoONDVkXYPWPj4Vp_g71or0sa0q2ZJlTlNmvfwKkk130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841557.RAFSzoONDVkXYPWPj4Vp_g71or0sa0q2ZJlTlNmvfwKkk130_provenance.